title: Chronic antithrombotic therapy in cataract surgery: How much evidence do we have?
authors.affiliation: Instituto de Ojos Santa Lucía, Paraná, Entre Ríos, Argentina.
authors.forename: G
authors.initials: G
authors.lastname: Crisci
authors.affiliation: Instituto de Ojos Santa Lucía, Paraná, Entre Ríos, Argentina. Electronic address: carlabrec@hotmail.com.
authors.forename: C
authors.initials: C
authors.lastname: Mendoza Breczinski
authors.affiliation: Instituto de Ojos Santa Lucía, Paraná, Entre Ríos, Argentina.
authors.forename: M
authors.initials: M
authors.lastname: Magurno
mesh_terms: D000758:Anesthesia / Q000009:adverse effects / Q000379:methods; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D002386:Cataract / Q000150:complications; D002387:Cataract Extraction; D000075202:Contraindications; D005130:Eye Hemorrhage / Q000139:chemically induced / Q000209:etiology / Q000517:prevention & control*; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D019934:International Normalized Ratio; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D019106:Postoperative Hemorrhage / Q000139:chemically induced / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D019851:Thrombophilia / Q000150:complications / Q000188:drug therapy
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors